American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited
Juliao AA, Plata M, Kazzazi A, Bostanci Y, Djavan B. Curr Opin Urol. 2012 Jan;22(1):34-9.

Source

aUROCENTRO Medical Center, Barranquilla, Colombia, South America bUniversity Hospital - Fundación Santa Fé de Bogotá, Department of Urology, Universidad de los Andes, Bogota, Colombia, South America cDepartment of Urology, New York University School of Medicine, NYU, New York, USA.

Abstract

PURPOSE OF REVIEW:

The purpose of this review is to provide a complete revision of two of the most widely used clinical guidelines in the management of lower urinary tract symptoms induced by benign prostatic hyperplasia and their importance and compliance among urologists.

RECENT FINDINGS:

Updates of the American Association of Urology and European Association of Urology clinical practice guidelines (CPGs) were reviewed and analyzed. Literature concerning compliance and application of these two CPGs in the different working scenarios of practicing has been evaluated.

SUMMARY:

Urology has moved to an era in which costs and quality of care are being scrutinized, and compliance to CPGs will be assessed. Practicing urologists do not have the time to keep up to date with the continuous incoming literature and CPGs are a great tool to give the highest quality of care to our patients.